Skip to main content
GDRXGoodRx Holdings, Inc.Sell4.4·$3.51-0.57%

GoodRx Holdings (GDRX) Q2 2026 earnings — TrendMatrix coverage

IN LINE+0.4% vs estimateEPS $0.08 vs $0.08 estVerdict Buy (Wait)Hold

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.08
Estimate
$0.08
Surprise
+0.4%
Revenue (period 2026-06-30)
$200.4M
Score at report (before → after)
4.84.8/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

GoodRx Holdings (GDRX) reported diluted EPS of $0.08, in line with the $0.08 estimate. TrendMatrix's engine moved from Buy (Wait) (4.8/10) to Hold at 4.8/10 after the report.

Current read · as of 2026-09-06

Where TrendMatrix's rating stands now

TrendMatrix currently rates GDRX Sell at 4.4/10.

0 of the last 4 quarters beat the estimate; this quarter's +0.4% surprise compares with a -3.9% four-quarter average. Next scheduled report: 2026-11-03.

What supports the rating

  • Sector modifier (Healthcare): +0.5

What argues against it

  • Concentration risk — Product: prescription transactions offering (68.0%)
  • Analyst target reached - limited upside remaining
  • V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8)

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$3.51
Price target
$3.51
Stop
$3.32
Upside to target
0.0%
Reward-to-risk
0.1:1

The stock trades at 58.0× trailing but 9.8× forward earnings — consensus estimates already build in a substantial earnings recovery.

Model outputs from TrendMatrix’s engine as of 2026-09-06 — shown for context, not personalized investment advice.

Healthcare context

GDRX at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Health Information Services
Market cap
$1.19B
P/E (fwd)
9.8
P/E (ttm)
58.0
52-week range
$1.77$5.81
Off 52-week high
39.6%
RSI (14)
37
Volume vs avg
0.51×
Score today
4.4/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks GDRX Earnings Q2 2026 earnings